{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T13:47:08Z","timestamp":1792936028066,"version":"4.5.0"},"reference-count":51,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014034","name":"FOREUM","doi-asserted-by":"crossref","award":["ECR 2020"],"award-info":[{"award-number":["ECR 2020"]}],"id":[{"id":"10.13039\/501100014034","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,6,24]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistently active rheumatoid arthritis (pactiveRA) may be due to the interplay between biological and non-biological factors. The role of socioeconomic factors remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore which biological and non-biological factors associate with pactiveRA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults with early RA in the National Early Inflammatory Arthritis Audit, recruited from May 2018 to October 2022, were included if having pactiveRA or persistently low RA (plowRA). The pactiveRA was defined as three consecutive Disease Activity Score-28 joints (DAS28) of &gt;3.2 at baseline, 3 and 12\u2009months. The plowRA was defined as DAS28 \u22643.2 at 3 and 12\u2009months. Stepwise forward logistic regression was used to explore associations with pactiveRA (outcome). Age and gender were included a priori, with socioeconomic factors and comorbidities as exposure variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>682 patients with pactiveRA and 1026 plowRA were included. Compared with plowRA, patients with pactiveRA were younger (58, IQR: 49\u201367) versus (62, IQR: 52\u201372), and included more women (69% vs 59%). The pactiveRA was associated with worse scores in patient-reported outcomes at baseline, and anxiety and depression screens. Overall, there was clear social patterning in pactiveRA, with age-by-gender interaction. Logistic regression indicated age, gender, social deprivation and previous or current smoking, were independently associated with pactiveRA, after controlling for disease severity markers (seropositivity). Depression, lung disease, gastric ulcers and baseline corticosteroid use, were also associated with pactiveRA (p&lt;0.05 for all).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Socioeconomic factors and deprivation were associated with pactiveRA, independent of clinical and disease characteristics. Identifying \u2018adverse\u2019 socioeconomic drivers of pactiveRA can help tailor interventions according to individual need.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2024-004180","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T10:45:27Z","timestamp":1720953927000},"page":"e004180","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit"],"prefix":"10.1136","volume":"10","author":[{"given":"Maryam","family":"Adas","sequence":"first","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London Faculty of Life Sciences & Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6858-4338","authenticated-orcid":false,"given":"Mrinalini","family":"Dey","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London Faculty of Life Sciences & Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-9963","authenticated-orcid":false,"given":"Sam","family":"Norton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London Faculty of Life Sciences & Medicine, London, UK"},{"name":"Health Psychology, King's College London Department of Psychology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Lempp","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London Faculty of Life Sciences & Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8962-5642","authenticated-orcid":false,"given":"Maya H","family":"Buch","sequence":"additional","affiliation":[{"name":"The University of Manchester Centre for Musculoskeletal Research, Manchester, UK"},{"name":"NIHR Manchester Biomedical Research Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cope","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London Faculty of Life Sciences & Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1230-2781","authenticated-orcid":false,"given":"James","family":"Galloway","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London Faculty of Life Sciences & Medicine, London, UK"},{"name":"Department of Rheumatology, King's College Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-3726","authenticated-orcid":false,"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London Faculty of Life Sciences & Medicine, London, UK"},{"name":"Department of Rheumatology, King's College Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,14]]},"reference":[{"key":"2025090312342085000_10.3.e004180.1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"key":"2025090312342085000_10.3.e004180.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13103"},{"key":"2025090312342085000_10.3.e004180.3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-020-02380-z","article-title":"Long-term remission and biologic persistence rates: 12-year real-world data","volume":"23","author":"Murray","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025090312342085000_10.3.e004180.4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.semarthrit.2018.09.003","article-title":"Are Prognostic factors adequately selected to guide treatment decisions in patients with rheumatoid arthritis? A collaborative analysis from three observational cohorts","volume":"48","author":"Baganz","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2025090312342085000_10.3.e004180.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1484-9","article-title":"Predictors of remission with Etanercept-methotrexate induction therapy and loss of remission with Etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial","volume":"20","author":"Smolen","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025090312342085000_10.3.e004180.6","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1093\/rheumatology\/keaa860","article-title":"Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease","volume":"60","author":"Roodenrijs","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312342085000_10.3.e004180.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217344"},{"key":"2025090312342085000_10.3.e004180.8","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002058","article-title":"Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review","volume":"8","author":"Dey","year":"2022","journal-title":"RMD Open"},{"key":"2025090312342085000_10.3.e004180.9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220249"},{"key":"2025090312342085000_10.3.e004180.10","unstructured":"NICE . NICE quality standard for rheumatoid arthritis in over 16S. 2020. Available: https:\/\/www.nice.org.uk\/guidance\/qs33"},{"key":"2025090312342085000_10.3.e004180.11","unstructured":"British Society for Rheumatology . National Early Inflammatory Arthritis Audit (NEIAA) second annual report.2023. Available: https:\/\/www.rheumatology.org.uk\/Portals\/0\/Documents\/Practice_Quality\/Audit\/NEIA\/2022\/NEIAA%20Fourth%20Annual%20Report_FINAL_11.01.23.pdf?ver=2023-01-11-165709-690"},{"key":"2025090312342085000_10.3.e004180.12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/rheumatology\/keac266","article-title":"Worse outcomes linked to Ethnicity for early inflammatory arthritis in England and Wales: a national cohort study","volume":"62","author":"Adas","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312342085000_10.3.e004180.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab107"},{"key":"2025090312342085000_10.3.e004180.14","unstructured":"Assets.publishing.service.Gov.UK. 2022. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/464430\/English_Index_of_Multiple_Deprivation_2015_-_Guidance.pdf"},{"key":"2025090312342085000_10.3.e004180.15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acr.22456","article-title":"Validation of the rheumatic disease Comorbidity index","volume":"67","author":"England","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312342085000_10.3.e004180.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.084459"},{"key":"2025090312342085000_10.3.e004180.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh297"},{"key":"2025090312342085000_10.3.e004180.18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.50.6.613"},{"key":"2025090312342085000_10.3.e004180.19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00004"},{"key":"2025090312342085000_10.3.e004180.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.20549"},{"key":"2025090312342085000_10.3.e004180.21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/key240","article-title":"Validation of the musculoskeletal health questionnaire in inflammatory arthritis: a Psychometric evaluation","volume":"58","author":"Norton","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312342085000_10.3.e004180.22","doi-asserted-by":"publisher","DOI":"10.1177\/0962280210395740"},{"key":"2025090312342085000_10.3.e004180.23","doi-asserted-by":"crossref","DOI":"10.1186\/s41512-020-00074-3","article-title":"State of the art in selection of variables and functional forms in multivariable analysis\u2014outstanding issues","volume":"4","author":"Sauerbrei","year":"2020","journal-title":"Diagn Progn Res"},{"key":"2025090312342085000_10.3.e004180.24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/keab598","article-title":"Predictors of poor function in RA based on two prospective UK inception cohorts","volume":"61","author":"Busby","year":"2022","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2025090312342085000_10.3.e004180.25","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1093\/rheumatology\/keac139","article-title":"The role of Comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort data","volume":"61","author":"Busby","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312342085000_10.3.e004180.26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.19400","article-title":"Socioeconomic disparities in functional status in a national sample of patients with rheumatoid arthritis","volume":"4","author":"Izadi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"#cr-split#-2025090312342085000_10.3.e004180.27.1","doi-asserted-by":"crossref","unstructured":"Zhao SS , Kearsley-Fleet L , Rogers K , et al . POS0054\u2005SOCIOECONOMIC deprivation is associated with reduced response and lower treatment persistence with anti-TNF therapies in people with rheumatoid arthritis. EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy","DOI":"10.1136\/annrheumdis-2023-eular.3449"},{"key":"#cr-split#-2025090312342085000_10.3.e004180.27.2","doi-asserted-by":"crossref","unstructured":"June 2023 doi:10.1136\/annrheumdis-2023-eular.3449","DOI":"10.1136\/annrheumdis-2023-eular.3449"},{"key":"2025090312342085000_10.3.e004180.28","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/rheumatology\/keac662","article-title":"Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study","volume":"62","author":"Witkam","year":"2022","journal-title":"Rheumatol (Sunnyvale)"},{"key":"2025090312342085000_10.3.e004180.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew309"},{"key":"2025090312342085000_10.3.e004180.30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.aje.a112878","article-title":"The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality","volume":"111","author":"Linos","year":"1980","journal-title":"Am J Epidemiol"},{"key":"2025090312342085000_10.3.e004180.31","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056937"},{"key":"2025090312342085000_10.3.e004180.32","first-page":"214","article-title":"The influence of sex on rheumatoid arthritis: a prospective study of Onset and outcome after 2 years","volume":"31","author":"Tengstrand","year":"2004","journal-title":"J Rheumatol"},{"key":"2025090312342085000_10.3.e004180.33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/rheumatology\/kex239","article-title":"Female hormonal factors and the development of anti-Citrullinated protein antibodies in women at risk of rheumatoid arthritis","volume":"56","author":"Alpizar-Rodriguez","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312342085000_10.3.e004180.34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/rheumatology\/keac357","article-title":"Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with Tocilizumab and csDMARDs","volume":"62","author":"Daraghmeh","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312342085000_10.3.e004180.35","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.909879","article-title":"What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis","volume":"9","author":"Raine","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025090312342085000_10.3.e004180.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.031666"},{"key":"2025090312342085000_10.3.e004180.37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/acr.23014","article-title":"Secular changes in clinical features at presentation of rheumatoid arthritis: increase in Comorbidity but improved inflammatory States","volume":"69","author":"Nikiphorou","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312342085000_10.3.e004180.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213687"},{"key":"2025090312342085000_10.3.e004180.39","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1965.03860140064013"},{"key":"2025090312342085000_10.3.e004180.40","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/745829","article-title":"Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in Olmsted County","volume":"2011","author":"Myasoedova","year":"2011","journal-title":"Gastroenterol Res Pract"},{"key":"2025090312342085000_10.3.e004180.41","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068015"},{"key":"2025090312342085000_10.3.e004180.42","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes262"},{"key":"2025090312342085000_10.3.e004180.43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev306"},{"key":"2025090312342085000_10.3.e004180.44","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001376","article-title":"Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features","volume":"6","author":"Fragoulis","year":"2020","journal-title":"RMD Open"},{"key":"2025090312342085000_10.3.e004180.45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/acr.20345","article-title":"Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis","volume":"63","author":"Margaretten","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312342085000_10.3.e004180.46","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211284"},{"key":"2025090312342085000_10.3.e004180.47","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq327"},{"key":"2025090312342085000_10.3.e004180.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198975","article-title":"The Association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases","volume":"13","author":"Enns","year":"2018","journal-title":"PLoS ONE"},{"key":"2025090312342085000_10.3.e004180.49","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez222"},{"key":"2025090312342085000_10.3.e004180.50","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/rheumatology\/keaa027","article-title":"Predictors of Presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis","volume":"59","author":"Gwinnutt","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2024-004180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:34:31Z","timestamp":1756928071000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2024-004180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,7,14]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/rmdopen-2024-004180"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2024-004180","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}